background
realtim
revers
transcript
polymeras
chain
reaction
rtpcr
target
select
gene
rna
main
diagnost
tool
global
respons
pandem
howev
diagnost
accuraci
test
studi
systemat
outsid
laboratori
set
aim
studi
provid
estim
diagnost
sensit
specif
rtpcr
test
develop
china
cdc
method
studi
design
secondari
analysi
publish
find
patient
wuhan
china
test
posit
neg
sensit
specif
reconstruct
use
bayesian
approach
probabilist
knowledg
diagnost
error
predict
valu
test
calcul
result
estim
number
confirmatori
test
need
establish
presenc
absenc
depend
prior
probabl
patient
diseas
result
sensit
rtpcr
diagnost
test
estim
ci
specif
ci
confid
interv
includ
sampl
error
addit
error
due
probabilist
knowledg
data
discuss
chines
version
rtpcr
test
conspicu
rate
fals
neg
result
like
miss
patient
patient
caus
diseas
outbreak
began
wuhan
china
last
quarter
year
later
identifi
novel
coronaviru
label
sinc
caus
sever
acut
respiratori
syndrom
diseas
associ
term
public
genom
led
rapid
develop
januari
realtim
revers
transcript
polymeras
chain
reaction
rtpcr
test
diagnosi
avoid
crossreact
known
coronavirus
one
version
develop
china
target
n
gene
viral
rna
anoth
version
develop
germani
target
rdrp
e
n
gene
realtim
rtpcr
test
develop
implement
thereaft
mani
laboratori
around
world
even
becam
global
pandem
continu
spread
rapidli
time
list
test
protocol
maintain
onlin
world
health
organ
rapid
develop
deploy
rtpcr
test
essenti
abil
measur
control
spread
howev
urgenc
pandem
allow
time
reliabl
adequ
power
clinic
studi
conduct
measur
diagnost
limit
rtpcr
test
present
bulk
knowledg
sensit
specif
rtpcr
base
laboratori
measur
goal
relat
minimum
threshold
detect
viral
load
requir
number
thermal
cycl
chain
reaction
attent
given
viral
distribut
physic
locat
differ
posit
rate
rtpcr
nasopharyng
versu
oropharyng
swab
sputum
bronchoalveolar
lavag
fluid
factor
impact
diagnost
success
rtpcr
includ
time
test
rel
diseas
onset
adequaci
volum
fluid
collect
swab
deviat
laboratoryrecommend
protocol
realworld
condit
term
clinic
decisionmak
caus
failur
test
lead
incorrect
diagnos
due
fals
posit
fals
neg
issu
receiv
media
attent
recent
editori
written
professor
medicin
influenti
us
newspap
urg
physician
bewar
fals
neg
diagnost
test
acknowledg
reliabl
data
rate
fals
neg
yet
avail
studi
provid
time
assess
diagnost
sensit
specif
rtpcr
base
sampl
patient
wuhan
china
origin
studi
aim
measur
accuraci
chest
ct
imag
diagnosi
assum
rtpcr
gold
standard
howev
author
provid
addit
inform
statu
patient
allow
reconstruct
sensit
specif
rtpcr
context
clinic
decisionmak
knowledg
efficaci
limit
rtpcr
even
known
chines
version
test
time
expect
provid
valuabl
refer
medic
practition
research
frontlin
fight
pandem
find
implic
polici
maker
well
polici
pandem
control
condit
limit
avail
test
high
rate
fals
neg
starkli
differ
polici
presenc
abund
suppli
diagnost
test
excel
predict
valu
data
data
publish
find
use
studi
studi
includ
patient
suspect
wuhan
china
underw
rtpcr
chest
ct
imag
diagnost
test
period
month
januari
februari
mean
age
report
year
male
throat
swab
sampl
collect
rtpcr
assay
report
use
taqman
onestep
rtpcr
kit
shanghai
huirui
biotechnolog
co
ltd
shanghai
biogerm
medic
biotechnolog
co
ltd
report
approv
use
china
food
drug
administr
rtpcr
test
posit
patient
neg
patient
although
test
treat
gold
standard
comparison
chest
ct
imag
studi
author
provid
valuabl
addit
inform
patient
neg
rtpcr
test
posit
test
chest
ct
reassess
basi
clinic
symptom
ct
featur
serial
ct
scan
studi
staff
conclud
among
patient
neg
rtpcr
test
could
classifi
highli
like
case
anoth
could
classifi
probabl
case
moreov
among
patient
posit
rtpcr
test
patient
classifi
neg
chest
ct
imag
studi
case
assum
low
chanc
fals
posit
align
implicit
assumpt
origin
studi
indic
choic
rtpcr
refer
comparison
chest
ct
imag
apart
role
identif
probabl
fals
posit
neg
rtpcr
chest
ct
imag
data
ignor
studi
summari
data
compos
firm
knowledg
rtpcr
test
result
probabilist
knowledg
number
fals
posit
fals
neg
rang
notat
use
true
fals
posit
neg
present
tabl
modifi
bayesian
approach
adopt
estim
uncertainti
aros
imprecis
knowledg
data
data
denot
x
consist
conting
tabl
repres
observ
joint
distribut
rtpcr
decis
posit
neg
binari
diseas
statu
present
absent
sinc
number
posit
neg
test
known
data
uniqu
defin
number
fals
posit
present
absent
row
sum
ccbi
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
number
fals
neg
ie
x
x
uncertainti
data
stem
uncertainti
valu
random
variabl
distribut
estim
level
confid
express
fals
identif
procedur
similar
fuzzi
logic
linguist
uncertainti
term
highli
like
probabl
repres
membership
function
although
motiv
fuzzi
logic
treatment
use
strictli
base
probabl
theori
start
point
inform
distribut
defin
probabl
space
diagnost
error
upon
calcul
result
distribut
estim
valu
distribut
sensit
specif
deriv
joint
distribut
detail
given
approach
thu
bayesian
comput
sens
start
inform
distribut
akin
inform
prior
distribut
end
distribut
desir
paramet
howev
termin
point
analysi
describ
distribut
paramet
use
term
prior
posterior
distribut
avoid
moreov
likelihood
function
data
calcul
differ
interpret
one
obtain
normal
condit
data
firmli
known
given
probabl
fals
identif
likelihood
number
fals
posit
neg
obtain
binomi
distribut
number
trial
binomi
distribut
known
data
binomi
probabl
paramet
denot
aris
distribut
repres
degre
confid
express
fals
identif
thu
distribut
express
chanc
case
fals
posit
subscript
l
refer
low
chanc
pr
distribut
chanc
probabl
space
pr
binomi
distribut
probabl
number
trial
given
maximum
rang
known
similarli
distribut
express
high
medium
chanc
case
highli
like
fals
neg
probabl
fals
neg
respect
sum
nh
nm
equal
distribut
nh
nm
binomi
given
valu
along
number
binomi
trial
known
respect
beta
distribut
often
serv
conjug
distribut
binomi
distribut
use
describ
low
medium
high
level
confid
diagnost
error
identifi
ccbi
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
data
x
uniqu
specifi
sensit
specif
particular
valu
known
therefor
joint
distribut
pr
provid
map
distribut
sensit
specif
care
consider
describ
point
result
estim
expect
valu
sensit
specif
measur
uncertainti
valu
aros
imperfect
knowledg
data
anoth
sourc
uncertainti
due
sampl
error
estim
use
establish
method
standard
error
proport
lastli
studi
evalu
predict
valu
test
provid
chanc
diseas
patient
condit
upon
result
diagnost
test
sensit
condit
probabl
revers
use
bay
formula
provid
posit
predict
valu
test
similar
formula
express
probabl
patient
even
test
neg
ie
pr
neg
rtpcr
equat
pr
right
hand
side
interpret
preval
diseas
test
done
gener
popul
gener
pr
prior
probabl
presenc
diseas
also
appropri
interpret
present
circumst
test
reserv
larg
symptomat
patient
medic
figur
distribut
correspond
low
medium
high
confid
identif
diagnost
error
beta
distribut
paramet
beta
distribut
paramet
beta
distribut
paramet
ccbi
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
profession
may
suspect
patient
could
quantifi
prior
probabl
rtpcr
test
carri
test
result
decid
posterior
probabl
statist
analysi
done
use
r
program
languag
rstudio
softwar
environ
shape
paramet
beta
distribut
low
medium
high
confid
level
fals
test
result
pr
pr
pr
median
valu
th
th
percentil
given
respect
median
valu
th
th
percentil
equal
respect
median
valu
th
th
percentil
given
respect
distribut
shown
figur
maximum
likelihood
joint
distribut
figur
locat
solut
correspond
estim
patient
without
diseas
due
low
number
fals
posit
expect
valu
specif
high
contrast
high
fals
neg
count
reflect
lower
expect
valu
sensit
confid
interv
pr
led
correspond
limit
pr
pr
sensit
confid
interv
confid
interv
specif
rang
figur
depict
distribut
sensit
specif
confid
interv
mention
provid
measur
uncertainti
aros
imperfect
knowledg
data
addit
sampl
error
estim
standard
error
proport
evalu
endpoint
confid
interv
datarel
uncertainti
overal
confid
interv
incorpor
two
sourc
error
shown
tabl
impact
explor
select
differ
shape
paramet
beta
distribut
describ
low
medium
high
confid
first
narrow
beta
distribut
defin
use
shape
paramet
pr
pr
tabl
estim
valu
sensit
specif
rtpcr
diagnosi
set
refer
primari
choic
beta
distribut
low
medium
high
confid
level
identifi
diagnost
error
set
set
explor
result
assumpt
narrow
wider
beta
distribut
among
column
first
ci
repres
uncertainti
aris
imperfect
data
second
ci
includ
sampl
error
addit
data
uncertainti
pr
median
valu
respect
span
th
th
percentil
approxim
may
compar
distribut
describ
previous
second
wider
beta
distribut
defin
use
shape
paramet
pr
pr
pr
median
valu
respect
span
th
th
percentil
approxim
estim
valu
sensit
specif
confid
interv
shown
tabl
point
estim
paramet
show
littl
variat
choic
narrowerwid
beta
distribut
result
somewhat
narrowerwid
confid
interv
predict
valu
rtpcr
diagnost
test
shown
figur
prior
probabl
rang
two
curv
figur
show
posterior
probabl
presenc
test
result
posit
neg
addit
tabl
ccbi
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
level
third
neg
test
would
need
lower
probabl
rtpcr
test
commonli
use
diagnosi
mani
influenza
virus
coronavirus
includ
virus
respons
sar
coronaviru
outbreak
influenza
pandem
mer
coronaviru
outbreak
rtpcr
test
often
treat
gold
standard
comparison
diagnost
method
led
sourc
reliabl
data
diagnost
accuraci
clinic
practic
viru
cultur
process
consid
better
standard
take
sever
day
comparison
hour
need
rtpcr
test
one
comparison
rtpcr
found
sensit
greater
rel
viru
cultur
diagnosi
influenza
high
accuraci
rtpcr
also
report
mer
hand
low
accuraci
report
detect
sar
realtim
rtpcr
although
rate
detect
improv
refin
laboratori
method
current
pandem
great
boon
rapid
develop
sever
version
rtpcr
diagnost
test
target
detect
differ
gene
viral
rna
laboratori
test
shown
least
one
version
rtpcr
assay
detect
viral
load
small
rna
copi
per
reaction
crossreact
known
coronavirus
particularli
primer
assay
wellchosen
howev
widespread
doubt
well
test
work
practic
one
sourc
error
aris
uncertain
distribut
viru
bodi
variou
time
diseas
trajectori
comparison
specimen
nasal
throat
tabl
predict
valu
rtpcr
diagnost
test
posterior
probabl
shown
prior
probabl
rang
along
number
confirmatori
test
need
establish
presenc
absenc
confid
level
ccbi
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
swab
indic
better
sensit
nasal
swab
diminish
sensit
throat
swab
particularli
first
day
diseas
onset
variat
sever
viral
infect
subject
anoth
sourc
error
milder
infect
like
escap
detect
sourc
error
includ
sampl
collect
storag
transport
error
collect
low
volum
fluid
swab
deplet
sampl
laboratori
error
assay
process
possibl
sensit
specif
diagnost
test
use
rtpcr
estim
studi
may
consid
provid
cumul
impact
variou
possibl
sourc
error
clear
sensit
test
weakest
aspect
specif
appear
good
case
may
gone
undetect
rtpcr
diagnost
test
design
china
cdc
implement
taqman
onestep
rtpcr
kit
far
medic
practition
concern
predict
valu
diagnost
test
utmost
import
medic
practition
suspect
chanc
patient
diseas
subsequ
posit
rtpcr
test
would
increas
chanc
hand
neg
rtpcr
test
patient
still
chanc
diseas
second
confirmatori
neg
test
would
need
bring
chanc
diseas
possibl
diagnost
error
mitig
action
medic
profession
might
taken
critic
view
neg
test
result
symptomat
patient
nevertheless
fals
neg
rate
still
like
among
main
reason
difficulti
control
breakout
earli
stage
problem
fals
neg
impli
public
health
measur
reli
singl
isol
case
unlik
success
larg
scale
instanc
true
preval
popul
test
would
miss
approxim
case
everi
peopl
test
highli
transmiss
viru
continu
propag
misdiagnos
case
proport
throat
swab
specimen
posit
rtpcr
test
conduct
patient
confirm
report
mere
almost
twice
much
sever
case
mild
case
anoth
studi
neither
valu
equival
sensit
defin
studi
multipl
specimen
drawn
smaller
set
particip
mention
studi
nonetheless
seem
reason
conclud
sensit
estim
studi
higher
suggest
mention
studi
possibl
reason
might
viral
load
may
higher
data
collect
epicent
pandem
hand
worth
note
sensit
rtpcr
estim
studi
close
align
valu
report
sensit
detect
sar
rtpcr
perhap
similar
surpris
sinc
genom
two
virus
report
similar
primari
limit
studi
estim
sensit
specif
appli
particular
version
rtpcr
test
urgent
creat
use
wuhan
china
januari
februari
laboratori
around
world
react
rapidli
pandem
creat
version
rtpcr
test
well
test
type
may
expect
experiment
done
protocol
procedur
result
chang
perform
rtpcr
test
develop
later
anoth
limit
studi
retrospect
studi
base
probabilist
knowledg
diagnost
error
studi
design
compar
diagnost
accuraci
rtpcr
better
gold
standard
method
would
abl
provid
definit
estim
narrow
confid
interv
data
sever
infect
sampl
patient
measur
viral
load
found
rtpcr
test
cycl
threshold
avail
anoth
limit
factor
studi
diagnost
sensit
specif
rtpcr
test
reconstruct
data
patient
wuhan
china
uncertainti
aros
incomplet
knowledg
joint
distribut
test
result
diseas
statu
quantifi
modifi
bayesian
analysi
along
quantif
uncertainti
due
sampl
error
result
indic
rtpcr
test
administ
via
throat
swab
conspicu
rate
fals
neg
result
like
miss
patient
patient
suspect
higher
roughli
chanc
least
two
confirmatori
neg
rtpcr
test
would
necessari
reduc
likelihood
diseas
limit
studi
find
appli
one
version
rtpcr
diagnost
test
develop
distribut
urgent
china
cdc
studi
find
may
gener
version
rtpcr
test
use
divers
geograph
region
